Program Description:
This complimentary performance improvement (PI) CME activity was designed to help primary care providers (physicians, nurse practitioners, and physician assistants) improve their skills in the assessment, diagnosis, and treatment of adults with ADHD. PI activities are structured, long-term programs that you can use to retrospectively assess care in your practice based on specific performance measures, apply such measures prospectively over a meaningful period of time, and re-assess your performance. To accomplish this, you will have access to a comprehensive NACE Adult ADHD Toolkit that will contain guidelines, webcasts, assessment tools, and patient education materials.
ACCREDITATION STATEMENT:
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The National Association for Continuing Education designates this educational activity for a maximum of 20
AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
STATEMENT OF NEED:
ADHD in adults is associated with increased health risks and increased healthcare costs, higher divorce rates, lower levels of socioeconomic attainment, lower academic achievement, unemployment and work place issues, increased risks for motor vehicle accidents, greater likelihood of other psychiatric disorders, and higher rates of substance use and abuse. Despite this being a disorder with serious impact on health and overall functioning, the vast majority of adult patients with ADHD remains undiagnosed and, therefore, untreated.1, 2
This activity will enable participants to have a better understanding of the etiology of ADHD, characteristics of ADHD in adults, and appropriate assessment tools to collect meaningful data (interview protocols, rating scales, symptom checklists, etc) for the evaluation of ADHD and co-existing psychiatric conditions. Participants will become more aware of treatment guidelines, safety and efficacy of pharmacologic interventions, and benefits of psychosocial interventions such as cognitive-behavioral therapy, coaching, work/school accommodations, community resources and ADHD education that can help adults with ADHD.
1. Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, Faraone SV, Greenhill LL, Howes MJ, Secnik K, Spencer T, Ustun TB, Walters EE, Zaslavsky AM. (2006). The Prevalence and Correlates of Adult ADHD in the United States: Results from the National Comorbidity Survey Replication. Amer. Jour. of Psychiatry, 163: 724-732.
2. Barkley, R.A., Murphy, K.R., & Fischer, M. (2008). ADHD in Adults: What the science says. Guilford Press, New York.
TARGET AUDIENCE:
Primary care providers including physicians, physician assistants, and nurse practitioners.
Activity Objectives:
- Evaluate your current practice behavior and confidence with respect to diagnosing and treating adults with ADHD in your practice
- Describe existing guidelines and best practices in the diagnosis and treatment of ADHD in adults
- Identify evidence-based and consensus-based tools to evaluate symptoms, level of impairment, and relevant history in adult patients suspected of having ADHD
- Identify risks for co-morbidities in adult patients with ADHD with emphasis on anxiety disorders, mood disorders, and substance use/abuse disorders
- Plan a pharmacologic treatment program for adults diagnosed with simple ADHD and more complex ADHD that is complicated by co-morbidities
- Identify psychosocial treatments for adults diagnosed with ADHD
- Discuss treatment follow-up to optimize success
- Create an action plan that addresses your specific practice behavior that needs improvement with respect to the care of adults with ADHD
Faculty:
Course Directors
Anne Teeter Ellison, Ed.D.
Professor Emeritus
University of Wisconsin
Gregg Sherman, MD
Family Practice
Faculty
Lenard A. Adler, MD
Departments of Psychiatry and Child and Adolescent Psychiatry
New York University School of Medicine
VA Harbor Healthcare System
Russell A. Barkley, Ph.D.
Clinical Professor of Psychiatry
Medical University of South Carolina
Research Professor of Psychiatry at SUNY Upstate Medical School
Kevin Murphy, Ph.D.
Director, The Adult ADHD Clinic of Central Massachusetts
Associate Research Professor at SUNY Upstate Medical Center
J. Russell Ramsay, Ph.D.
Associate Director, ADHD Treatment and Research Program
Assistant Professor of Psychology in Psychiatry Department of Psychiatry
University of Pennsylvania
Anthony Rostain, M.D., M.A.
Director of Education, Department of Psychiatry
University of Pennsylvania Health System
Richard L. Rubin, MD
Director, The Vermont Clinical Study Center
Adjunct Associate Professor at Dartmouth Medical College
Disclosures:
Accreditor Disclosure:
It is the policy of the National Association for Continuing Education to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the National Association for Continuing Education are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.
Course Directors, Faculty and Planners Disclosures
Lenard Adler, MD, has received grant/research support from AstraZeneca Pharmaceuticals, Bristol-Myers Squibb, Pfizer, Shire, Eli Lilly, Ortho McNeil/Jannsen/Johnson and Johnson, National Institute of Drug Abuse. Dr. Adler is on the advisory board and is a consultant for Eli Lilly, Major League Baseball, Mindsite, Organon, Ortho McNeil/Jannsen/Johnson and Johnson, Otsuka Pharmaceuticals, Shire, i3 Research, and Epi-Q, INC.
Russell A. Barkley, Ph.D., is on the speakers’ bureau and is a consultant for Eli Lilly, Shire, McNeil, Janssen-Orth, Janssen-Cilag, and Novartis.
Kevin Murphy, Ph.D., is on the speakers’ bureau for Shire.
Russell Ramsay, Ph.D., has nothing to disclose.
Anthony Rostain, MD, MA, is on the advisory board for Shire, and Ortho-McNeill-Janssen
Richard L. Rubin, MD, has received research support, is a consultant and on the speakers’ bureaus for Abbott, Cephalon, Eli Lilly, Johnson & Johnson, Novartis, Shionogi, and Shire.
Gregg Sherman, MD, has nothing to disclose.
Anne Teeter Ellison, Ed.D., has nothing to disclose.
Harvey C. Parker, Ph.D., CCMEP, Owner of Specialty Press, Inc. and Health Link Systems, Inc.
Michelle Frisch, MPH, CCMEP, has nothing to disclose.
Alan Goodstat, LCSW, has nothing to disclose.
Jill Foster, MD, MPH, CE Outcomes, LLC, has nothing to disclose.
Nancy Roepke, CE Outcomes, LLC, has nothing to disclose.
Stephen Burton, CE Outcomes, LLC, has nothing to disclose.
This activity is sponsored by the National Association for Continuing Education (NACE)
If you have any questions relating to the accreditation of this activity, please contact Sharon Graham at info@naceonline.com.
This educational activity is supported by an educational grant from Lilly USA, LLC. For further information concerning Lilly grant funding, visit www.lillygrantoffice.com.
For full program information, please click on “BEGIN” and follow the next click through to reach this program site. Once you get to the “NACE” home page, you will register, review the content, take the test and receive credit.
SYSTEM REQUIREMENTS:
WINDOWS PC SYSTEM REQUIREMENTS:
266-MHz Pentium II; Windows 98 or higher; 64 MB RAM; 800 x 600 screen resolution
set for “High Color (16-Bit)”; Macromedia Flash Player 6 or higher.
MACINTOSH® SYSTEM REQUIREMENTS:
Power Mac g3 at 300 MHz; System 8.5 or higher (excluding Mac OSX); 96 MB RAM; 20
MB minimum hard disk space available; 800 x 600 screen resolution set to “Thousands
of Colors”; Macromedia Flash Player 6 or higher.